USA-based biosciences startup, TenSixteen jas raised $40 million in its Series A funding round from Foresite Capital and GV.... Jan 29
Pharma merger and acquisition news... Jul 22
... Apr 24
The curfew has been enforced from April 12, 9 PM till April 19, 6 am... Apr 13
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug, Truvada Tablets, 200 mg/300 mg, of Gilead Sciences... Jan 15
Top ten mid cap Indian pharma stocks , January 2021... Jan 07
Preliminary data from the non-powered U.S. Phase 2 study of 40 hospitalized patients shows that orally-administered opaganib was safe, with no material ... Jan 02
Gilead and Galapagos will continue to investigate the potential for filgotinib to support patients living with Inflammatory Bowel Disease... Dec 16
Grantmakers In Aging, a national membership organization of philanthropies, created Moving Ahead Together: A Framework for Integrating HIV/AIDS and Aging Services to help end ... Dec 09
Roche today announced a partnership with Moderna Inc. to utilize the Elecsys® Anti-SARS-CoV-2 S antibody test in Moderna’s mRNA-1273 vaccine ... Dec 09
With Remdesivir out from benchmark drugs for Covid Gilead could be severely impacted... Nov 21
Currently no evidence that it improves survival and other important measures ... Nov 20
A World Health Organization-led scheme to supply COVID-19 drugs to poor countries is betting on experimental monoclonal antibody treatments and steroids and shuns ... Nov 10
Ligand’s Partner Sedor Pharmaceuticals receives US FDA approval for SESQUIENT for the treatment of status epilepticus in adult and paediatric patients ... Nov 07
... Nov 07
WHO-led scheme to supply COVID-19 drugs to poor countries is betting on experimental monoclonal antibody treatments and steroids but shunning Gilead's GILD.... Nov 06
This trial will enroll approximately 330 HR+/HER2- mBC patients in Mainland China, Taiwan and South Korea... Nov 02
The agreement will enter into force as of 1st January 2021... Oct 27
The U.S. Food and Drug Administration on Thursday approved Gilead Sciences Inc’s antiviral drug remdesivir for treating patients hospitalized with COVID-19... Oct 23
The search for effective drug continues for severely affected Covid patients... Oct 17
The antiviral medication was one of the drugs used to treat U.S. President Donald Trump’s coronavirus infection, and has been shown in previous ... Oct 16
Increasing evidence suggests that some Covid-19 patients get very ill because of an impaired interferon response... Sep 25
ACTO cements its position as the largest life sciences commercial learning and development platform ... Sep 15
The coronavirus, SARS-CoV-2, is the latest in a procession of new infectious diseases that have surprised the world in recent years... Sep 15
Another Indian company joins Remdesivir production... Sep 15
-Advertisements-
Thursday, May 16, 2024
